Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Gustavo Zamperlini"'
1
Manuscript title Prospective evaluation of oral levetiracetam for prophylaxis of busulfan-induced seizures in children undergoing hematopoietic stem cell transplantation
Autor: Marcelo de Melo Aragão, Gustavo Zamperlini, Adriana Seber, Zecchin VG, Cintia Monteiro Lustosa, Ricardo Pinho, Marcelo Rodrigues
Busulfan is commonly used in the conditioning regimen for hematopoietic stem cell transplantation. Due to the risk of seizures associated with its use, prophylaxis with an anti-seizure drug is required. We prospectively evaluated the effectiveness of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::68d888a21831e2dd1f9077721de96b2b
https://doi.org/10.22541/au.168493000.07600763/v1
Zobrazit plný text záznamu
3
Successful Outcomes of Children Simultaneously Diagnosed with Acute Myeloid Leukemia and Covid-19: The Role of a Mild Chemotherapeutic Induction Regimen
Autor: Mecneide Mendes Lins, Luciana Nunes Silva, Alayde Vieira Wanderley, Laudreisa da Costa Pantoja, Valentino Conter, Adriana Seber, Gustavo Zamperlini, Cinthya Rocha, Raul C. Ribeiro, Juliana Teixeira Costa
Publikováno v: Blood
Introduction: Children with newly diagnosed acute myeloid leukemia (AML) may have a high early mortality when resources are limited by infrastructure or by a widespread worldwide crisis, as being faced with the SARS-Cov-2 pandemic. Many elective trea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ca457039db3dcda01c8c4f1d43989e
http://europepmc.org/articles/PMC8330160
Zobrazit plný text záznamu
4
CONDITIONING REGIMEN FOR LANGERHANS HISTIOCYTOSIS
Autor: Gustavo Zamperlini, Monica Cypriano, Victor Gottardello Zecchin
Publikováno v: JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2:152
Langerhans cell histiocytosis (LCH) is a rare disease, with an estimated incidence of 0.5 per 100,000 children in the United States of America1. HCL occurs due to differentiation of myeloid precursors into CD1a+ / CD207+ cells and is characterized by
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9f949ebad87b6b437c9f89fe2cf0487d
https://doi.org/10.46765/2675-374x.2021v2n4p152
Zobrazit plný text záznamu
5
Myelodysplastic syndromes (MDS)
Autor: Gustavo Zamperlini, Simone de Castro Resende Franco, RV Gouveia, Patrícia Shimoda Ikeuti, Neysimelia Costa Villela, Luiz Fernando Lopes
Publikováno v: JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2:127
MDS in children is a rare group of hematopoietic stem cell clonal disorder. Allogeneic HSCT is the only curative treatment. HLA typing and the search for a compatible donor must be carried out upon diagnosis, for all patients. However, patients with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::259f01e6548e4582ec02128da2152862
https://doi.org/10.46765/2675-374x.2021v2n4p127
Zobrazit plný text záznamu
6
Myeloproliferative neoplasms
Autor: Neysimelia Costa Villela, Gustavo Zamperlini, Patrícia Shimoda Ikeuti, Roseane Vasconcelos Gouveia, Simone De Castro Resende Franco, Luiz Fernando Lopes
Publikováno v: JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2:129
In addition to the chronic myeloid leukemia (CML) BCR-ABL1+, classic myeloproliferative neoplasms include polycythemia vera, essential thrombocythemia and primary myelofibrosis. These have a very low incidence in the pediatric age group and there is
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1368f08efe3c911ac3bf427287795786
https://doi.org/10.46765/2675-374x.2021v2n4p129
Zobrazit plný text záznamu
7
Juvenile Myelomonocytic Leukemia and other myelodysplastic/myeloproliferative neoplasms
Autor: RV Gouveia, Neysimelia Costa Villela, Luiz Fernando Lopes, Patrícia Shimoda Ikeuti, Simone de Castro Resende Franco, Gustavo Zamperlini
Publikováno v: JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 2:128
Juvenile Myelomonocytic Leukemia (JMML) is a clonal hematopoietic disorder that usually occurs in early childhood, characterized by hyperactivation of the RAS signaling pathway. About 90% of patients have mutations in 1 of 5 genes (PTPN11, NRAS, KRAS
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::05434308db3a887b48093fa7caf6efcf
https://doi.org/10.46765/2675-374x.2021v2n4p128
Zobrazit plný text záznamu
8
Molecular Characterization of Pediatric Acute Myeloid Leukemia: Results of a Multicentric Study in Brazil
Autor: Rosania Basegio, Virginia Maria Coser, Marcelo Santos Souza, Renata Silva de Carvalho Gurgel, José Carlos Córdoba, Gustavo Zamperlini, Tállita Meciany Farias Vieira, Eloisa Cartaxo Eloy Fialho, Isis Q. Magalhães, Renato Melaragno, Maria S. Pombo-de-Oliveira, Eugênia Terra-Granado, Denise Browsfield Silva, Alejandro Mauricio Arancibia, Elda Pereira Noronha, Maura Rosane Valério Ikoma, Luiz Claudio Santos Thuler, Ingrid Koster, Eny Guimarães Carvalho, Gisele Dallapicola Brisson, Patricia Carneiro de Brito, Suellen Valadares Moura, Filipe dos Santos Vicente Bueno, Claudia T. Oliveira, Á.S. Dias, Ilana Zalcberg Renault, Fernando Werneck, Francianne Gomes Andrade, Bruno Marcelo Rocha Freire, Ingrid Sardou Cezar, Terezinha de Jesus Marques Salles, Adriana Vanessa Santini Deyl, Ana Maria Marinho, Gustavo Ribeiro Neves, Ana Paula Ferreira Freund Winn, Imaruí Costa
Publikováno v: Archives of Medical Research. 47:656-667
Background and Aims The biological characterization of childhood acute myeloid leukemia (c-AML) is an important outcome predictor. In Brazil, very little is known about the frequency of AML subgroups, although c-AML accounts for about 18% of leukemia
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43693c9d9b0b390b4f154e0fbb273c53
https://doi.org/10.1016/j.arcmed.2016.11.015
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje